What can a rep cite when selling against each carrier?
Data through Multiple vintages (shown per fact) · Updated July 17, 2026
curated
5 carrier battlecards, each carrying the CMS-sourced facts a rep can cite in a competitive conversation, with the vintage on every fact. Star movement comes from official October ratings, exits from CMS non-renewal notices, momentum from contract enrollment extracts; benefit-value erosion is modeled and labeled as such.
-0.4★
Steepest star decline (Humana) since 2023
2026 Star Ratings (published Oct 2025)
148
Plans terminated for 2026 across all carriers
Plan year 2026 (announced fall 2025)
-23.9%
Deepest modeled benefit erosion (UHC); modeled, not CMS data
Plan years 2022–2026
Selling against UHC
Fact a rep can cite
Source
Vintage
Weighted star rating moved 4★ → 3.8★ (-0.2) across the 2023 to 2026 rating years, below the 4.0★ quality bonus threshold.
Terminated 62 plans for 2026, affecting 930K members across 13 states (FL, TX, OH, IL, MO, NE, more). Analyst note: margin recovery — exited unprofitable plans, trimmed benefits, and reduced networks.
CMS 2026 non-renewal notices
Plan year 2026 (announced fall 2025)
Tracked enrollment trend averages +1% YoY across 6 tracked states; weakest in TX at -6.2%, strongest in FL at +6.8%.
CMS contract enrollment extract
March 2026
Modeled benefit value down 23.9% vs the 2022 baseline (deep 2026 benefit cuts as part of margin-recovery plan). Modeled MedicareInsights estimate: directional context only, never citable as CMS data.
Tracked enrollment trend averages -3.6% YoY across 25 tracked states; weakest in FL at -11.4%, strongest in KY at +1.2%.
CMS contract enrollment extract
March 2026
Modeled benefit value down 14.7% vs the 2022 baseline (2023–2025 trims under mlr pressure). Modeled MedicareInsights estimate: directional context only, never citable as CMS data.
Terminated 14 plans for 2026, affecting 200K members across 3 states (PA, NY, NJ). Analyst note: northeast ppo product consolidation into hmo-only.
CMS 2026 non-renewal notices
Plan year 2026 (announced fall 2025)
Tracked enrollment trend averages +2.8% YoY across 3 tracked states; weakest in PA at 2.1%, strongest in FL at +3.4%.
CMS contract enrollment extract
March 2026
Modeled benefit value down 6.8% vs the 2022 baseline (tier 2 drug coverage narrowed in 6 markets). Modeled MedicareInsights estimate: directional context only, never citable as CMS data.
Terminated 11 plans for 2026, affecting 142K members across 3 states (IA, NE, KS). Analyst note: mid-market affiliate consolidation — plan id rationalization.
CMS 2026 non-renewal notices
Plan year 2026 (announced fall 2025)
Tracked enrollment trend averages +2.8% YoY across 3 tracked states; weakest in IL at 2.4%, strongest in TX at +3.2%.
CMS contract enrollment extract
March 2026
Modeled benefit value down 4.3% vs the 2022 baseline (minor otc adjustments in select markets). Modeled MedicareInsights estimate: directional context only, never citable as CMS data.
Terminated 34 plans for 2026, affecting 520K members across 6 states (WA, OR, ID, MT, FL, TX). Analyst note: broad ma retreat — enrollment fell below 1m; refocusing on d-snp counties.
CMS 2026 non-renewal notices
Plan year 2026 (announced fall 2025)
Tracked enrollment trend averages +14.5% YoY across 3 tracked states; weakest in PA at 12.4%, strongest in TX at +16.8%.
CMS contract enrollment extract
March 2026
Modeled benefit value down 5.6% vs the 2022 baseline (minimal — started with lean benefits; little to cut). Modeled MedicareInsights estimate: directional context only, never citable as CMS data.
The strongest competitive selling is a dated fact, not an adjective. A rep who can say which ratings fell, which plans were terminated, and where a rival is retrenching, with the CMS vintage attached, wins credibility that brochure claims cannot. Note the boundary: the benefit-value erosion series is a MedicareInsights model and is labeled as such on every card; cite it as directional context, never as CMS data.
Enablement: lift the facts verbatim into talk tracks, keeping the vintage with each fact; a dated CMS figure survives a compliance review, an undated claim does not.
Pair each card with the AEP target-markets page: a carrier's exit states are exactly where its former members are listening.
Mark October 2026: the 2027 star ratings (with KED at triple weight) and the 2027 non-renewal notices land days before AEP 2027 opens, and these cards refresh the week each file is ingested. The dated calendar is on the 2027 disruption pipeline page.
Contract-level disenrollment rates and the new public prior-auth data (from Jan 2027) join these cards when those CMS files are ingested, adding churn and denial-behavior signals per competitor for AEP 2028.
Each card lists the facts a rep can cite when selling against a carrier: star trajectory (CMS Star Ratings), 2026 plan exits (CMS non-renewal notices), enrollment momentum (CMS contract enrollment extract), and benefit-value erosion (modeled, labeled as such). Every fact carries the vintage of the dataset it comes from; underlying provenance panels are on the page.
Known limitations
The selection and phrasing of facts is editorial. The benefit-value series is a MedicareInsights model, labeled modeled, and is never citable as CMS data.